News
EURETINA 2025: Peter Kiraly, PhD, helps young retinal specialists break into the vitreoretinal space
The EURETINA YOURS program prepares retina specialists for the EBO exam and helps them find training in the competitive subspecialty of vitreoretinal surgery. The European Society of Retina ...
Prof. Androudi said differential diagnoses are more important than ever in the era of cell and gene therapies. Note: The following transcript has been lightly edited for clarity. Sofia Androudi, MD: ...
In the debut episode of The Retina TL;DR, host Christina Y. Weng, MD, MBA, FASRS, talks with Tony Stefater, MD, PhD, and Tommy Stryjewski, MD, about PYK-2101, a biodegradable retinal sealant designed ...
Beacon Therapeutics shares promising phase 2 trial results for laru-zova, a gene therapy showing potential in treating X-linked retinitis pigmentosa. Beacon Therapeutics recently revealed topline data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results